✦ LIBER ✦

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT

✍ Scribed by P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV38 COST-EFFECTIVENESS OF RIVAROXABAN

✍ J Kim; R Pollock; S Jung; A Diamantopoulos; M Lees 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

PCV93 THROMBOPROPHYLAXIS AFTER TOTAL KNE

✍ M Lukac; J Bielik; M Lees; D Tomek; V Foltan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCV86 COST-UTILITY ANALYSIS OF RIVAROXAB

✍ R Pereira; A Diamantopoulos; J Bielik; M Lees; D Tomek; M Lukac 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCV39 COST-EFFECTIVENESS OF DABIGATRAN E

✍ C Mateus; S Wolowacz; JA Pereira 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCV42 Cost Analysis of Venous Thromboemb

✍ B. Marmarali; F. Altintas; K. Bal; K. Bozkurt; M. Demir; B. Erdemli; B. Ince; G. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB